Renaissance Technologies’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.6M | Buy |
3,251,516
+295,200
| +10% | +$6.41M | 0.09% | 238 |
|
|
2025
Q1 | $71.7M | Buy |
2,956,316
+250,200
| +9% | +$6.07M | 0.11% | 224 |
|
|
2024
Q4 | $56.5M | Buy |
2,706,116
+180,100
| +7% | +$3.76M | 0.08% | 283 |
|
|
2024
Q3 | $50.2M | Buy |
2,526,016
+350,289
| +16% | +$6.96M | 0.08% | 323 |
|
|
2024
Q2 | $33.7M | Buy |
2,175,727
+287,300
| +15% | +$4.45M | 0.06% | 406 |
|
|
2024
Q1 | $30.1M | Buy |
1,888,427
+291,000
| +18% | +$4.64M | 0.05% | 472 |
|
|
2023
Q4 | $26.9M | Buy |
1,597,427
+308,327
| +24% | +$5.18M | 0.04% | 500 |
|
|
2023
Q3 | $15.1M | Buy |
1,289,100
+134,200
| +12% | +$1.57M | 0.03% | 700 |
|
|
2023
Q2 | $15.5M | Buy |
1,154,900
+64,800
| +6% | +$871K | 0.02% | 795 |
|
|
2023
Q1 | $18.1M | Sell |
1,090,100
-141,412
| -11% | -$2.34M | 0.02% | 778 |
|
|
2022
Q4 | $22.9M | Sell |
1,231,512
-995,000
| -45% | -$18.5M | 0.03% | 642 |
|
|
2022
Q3 | $28.6M | Buy |
2,226,512
+1,194,900
| +116% | +$15.3M | 0.04% | 504 |
|
|
2022
Q2 | $7.23M | Buy |
1,031,612
+678,500
| +192% | +$4.76M | 0.01% | 1302 |
|
|
2022
Q1 | $2.93M | Sell |
353,112
-69,774
| -16% | -$578K | ﹤0.01% | 1944 |
|
|
2021
Q4 | $2.86M | Buy |
422,886
+370,648
| +710% | +$2.51M | ﹤0.01% | 1877 |
|
|
2021
Q3 | $277K | Buy |
+52,238
| New | +$277K | ﹤0.01% | 3108 |
|
|
2020
Q2 | – | Sell |
-739,226
| Closed | -$2.85M | – | 3483 |
|
|
2020
Q1 | $2.85M | Buy |
739,226
+563,526
| +321% | +$2.17M | ﹤0.01% | 1868 |
|
|
2019
Q4 | $659K | Buy |
+175,700
| New | +$659K | ﹤0.01% | 2797 |
|
|
2018
Q4 | – | Sell |
-152,722
| Closed | -$577K | – | 3403 |
|
|
2018
Q3 | $577K | Buy |
152,722
+6,256
| +4% | +$23.6K | ﹤0.01% | 2806 |
|
|
2018
Q2 | $457K | Sell |
146,466
-1,243,034
| -89% | -$3.88M | ﹤0.01% | 2860 |
|
|
2018
Q1 | $3.32M | Buy |
1,389,500
+275,400
| +25% | +$658K | ﹤0.01% | 2055 |
|
|
2017
Q4 | $4.36M | Buy |
1,114,100
+532,500
| +92% | +$2.08M | ﹤0.01% | 1895 |
|
|
2017
Q3 | $1.47M | Sell |
581,600
-310,200
| -35% | -$782K | ﹤0.01% | 2429 |
|
|
2017
Q2 | $2.46M | Buy |
891,800
+509,400
| +133% | +$1.41M | ﹤0.01% | 2139 |
|
|
2017
Q1 | $746K | Buy |
+382,400
| New | +$746K | ﹤0.01% | 2641 |
|
|
2016
Q4 | – | Sell |
-15,000
| Closed | -$16K | – | 3269 |
|
|
2016
Q3 | $16K | Buy |
+15,000
| New | +$16K | ﹤0.01% | 3290 |
|
|
2016
Q2 | – | Sell |
-175,800
| Closed | -$206K | – | 3352 |
|
|
2016
Q1 | $206K | Buy |
+175,800
| New | +$206K | ﹤0.01% | 3076 |
|
|
2015
Q2 | – | Sell |
-21,227
| Closed | -$92K | – | 3243 |
|
|
2015
Q1 | $92K | Buy |
+21,227
| New | +$92K | ﹤0.01% | 3022 |
|
|
2014
Q4 | – | Sell |
-196,500
| Closed | -$652K | – | 2978 |
|
|
2014
Q3 | $652K | Buy |
+196,500
| New | +$652K | ﹤0.01% | 2220 |
|
|
2013
Q4 | – | Sell |
-138,500
| Closed | -$422K | – | 2868 |
|
|
2013
Q3 | $422K | Buy |
+138,500
| New | +$422K | ﹤0.01% | 2356 |
|